Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(Blistering diseases bullae )
3,356 results
  • Bullous autoimmune dermatoses. [Journal Article]
  • JDJ Dtsch Dermatol Ges 2018; 16(11):1339-1358
  • Hofmann SC, Juratli HA, Eming R
  • Pathophysiologically, bullous autoimmune dermatoses are caused by autoantibodies directed against adhesion molecules or structural proteins of the skin and mucous membranes, clinically resulting in b...
  • Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study. [Journal Article]
  • IJInt J Drug Policy 2018 Oct 20; 62:14-23
  • Cunningham EB, Amin J, … SIMPLIFY study group
  • CONCLUSIONS: This study demonstrated high adherence to once-daily sofosbuvir/velpatasvir therapy among a population of people with recent injecting drug use. Recent stimulant injecting prior to and during DAA therapy and inconsistent dose-timing during treatment was associated with non-adherence. However, there was no impact of non-adherence on response to therapy, suggesting that adherence is not a significant barrier to successful DAA therapy in people with recent injecting drug use.
  • Immunoglobulin E and bullous pemphigoid. [Journal Article]
  • EJEur J Dermatol 2018 Aug 01; 28(4):440-448
  • Cozzani E, Gasparini G, … Parodi A
  • Clinical features and histological findings in bullous pemphigoid (BP) suggest a Th2-oriented inflammatory reaction, especially in the early stages of the disease. Elevated total serum IgE levels, bl...
New Search Next